Pikdare S.p.A. ha diffuso questo post
MTD Group has successfully completed the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGMs) businesses, significantly progressing in its mission to serve more diabetic patients more completely. With this acquisition, MTD: ➡️Strengthens its position as the world's #2 player by increasing production capacity to over 2.5 billion pen needles. ➡️Enriches its portfolio to better cover diabetic patients and HCPs needs adding new Pen Needles with Click Technology for an easy and secure fit, an advanced sharpening geometry with up to 6 bevels, single & dual protection for HCP’s safety and - finally - a premium BGM. These top the current Pen Needle range, which includes the thinnest and shortest pen needle (G34), BGMs and CGMs (Continuous Glucose Monitoring) offering. ➡️Reaches 3bln new consumers by entering in China & India, strengthening its presence in other key markets including, North America, France & Germany. Read more https://lnkd.in/dV3SRW7d #DiabetesCare #HealthcareInnovation #Investment #Acquisition